MRNA News and Press, Moderna Inc.

2024-05-18 14:52:07 ET More on GSK, Johnson & Johnson, etc. Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Johnson & Johnson (JNJ) ...

2024-05-17 14:40:17 ET More on Stocks Hasbro: Fairly Priced As Turnaround Game Plan Is Playing Out Tesla is reportedly considering data centers in China FAA operational hold on United Airlines remains intact - update Moderna vaccine patent upheld by European ...

2024-05-17 13:25:19 ET More on Moderna Moderna Q1: A Promising Pipeline Is Undervalued Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Evercore says biotech ‘winter is finally thawing&#...

2024-05-17 05:40:00 ET Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% increase for ...

2024-05-16 14:08:55 ET Billionaire investor Philippe Laffont's Coatue Management exited its stakes in Apple ( NASDAQ: AAPL ) and Walt Disney ( NYSE: DIS ), picked up new positions in Qualcomm ( NASDAQ: QCOM ) and Broadcom ( AVGO ), and massively increased its hol...

2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...

2024-05-15 12:19:13 ET Summary Moderna reported better-than-expected 1Q24 revenue of $167 million. The FDA's decision on Moderna's RSV vaccine has been delayed, adding uncertainty to its potential approval and market entry. Moderna's pipeline looks promising. I have a bull...

2024-05-15 10:21:25 ET Short percentage in S&P 500’s healthcare companies dipped at the end of April from March, as the life science tools and services sub-sector saw a huge drop in short interest from the previous month, while biotechnology emerged as the most shorted sector.......

2024-05-14 11:24:32 ET More on BioNTech, Moderna, etc. BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Moderna announces del...

2024-05-14 06:35:00 ET Investors have put their hopes in Moderna 's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it represents a new revenue stream for a company that until now has relied on just one product, and a product strugg...